Cresset Asset Management, LLC

Position in HRMY — Harmony Biosciences Holdings, Inc.

CIK 1761013 Chicago, IL

Position in HRMY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,731,260

+$1,702,356 QoQ

Shares Held

102,479

+41.5% QoQ

Ownership

0.176%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#72

of 328 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Jun 30, 2026

Cresset Asset Management, LLC holds $108,155,066 across 44 Biotechnology names. HRMY ranks #5 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	736,708	$52,048,420
2	HALO	Halozyme Therapeutics, Inc.	260,937	$20,423,538
3	VRTX	Vertex Pharmaceuticals Inc / Ma	7,926	$3,937,081
4	EXEL	Exelixis, Inc.	70,918	$3,858,648
5	HRMY	Harmony Biosciences Holdings, Inc. This page	102,479	$3,731,260
6	TVTX	Travere Therapeutics, Inc.	35,433	$2,012,948
7	MRNA	Moderna, Inc.	28,359	$1,985,980
8	PVLA	Palvella Therapeutics, Inc.	11,629	$1,777,143

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,731,260	102,479	+41.5%	Shares	Sole	2026-08-14
2026-03-31	$2,028,904	72,435	+7.5%	Shares	Sole	2026-05-15
2025-12-31	$2,521,097	67,373	+0.3%	Shares	Sole	2026-02-17
2025-09-30	$1,850,709	67,152	+0.5%	Shares	Sole	2026-01-22
2025-06-30	$2,112,049	66,837	-3.1%	Shares	Sole	2026-01-22
2025-03-31	$2,288,815	68,961	-3.9%	Shares	Sole	2025-05-13
2024-12-31	$2,469,433	71,765	+11.8%	Shares	Sole	2025-02-14
2024-09-30	$2,568,320	64,208	+6.3%	Shares	Defined	2024-11-14
2024-06-30	$1,821,604	60,378	+18.7%	Shares	Defined	2024-08-14
2024-03-31	$1,707,945	50,862	—	Shares	Defined	2024-05-15
No filing history on record for this holder in this stock.